We are proud to present groundbreaking data at the 5th Swedish Diabetes Summit, revealing a novel approach to treating type 2 diabetes through VDAC1 oligomerization inhibitors. We share our exciting poster presented by our Principal Scientist Ruchi Jain and our...
World Diabetes Day on November 14 raised awareness of diabetes as one of the greatest public health challenges of our time, along with the importance of ensuring access to adequate care for everyone affected. Claes Wollheim, founder of Abarceo Pharma, has dedicated...
Adam Bruce, CEO & Chair of Abarceo Pharma, presents at Investing in Life Science – From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to...
BioStock’s Natasha Bank interviews Adam Bruce, CEO & Chair of Abarceo Pharma, at Investing in Life Science – From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life...
Today ABARCEO PHARMA is celebrating the birthday of Sir Frederick Banting, who discovered insulin. It is also the World Diabetes Day, this year with the theme, “Breaking Barries, Bridging Gaps”Truly the spirit that we at Abarceo live and work by in the...
Recent Comments